[Correlation between Expression Patterns of CD117/CD200 in Plasma Cells and Molecular Genetic Prognostic Parameters...

To investigate the correlation between the expression of CD117 and CD200 in plasma cells and molecular genetic abnormalities in patients with multiple myeloma (MM).

100 newly diagnosed MM patients were selected, and fresh bone marrow fluid was collected from the patients. The immunophenotypes and chromosomal structural variations of plasma cells were detected by flow cytometry (FCM) and fluorescence in situ hybridization (FISH).

The positive expression frequencies of CD117 and CD200 in abnormal plasma cells of all MM patients were 44.0% and 44.0%, respectively. At least one molecular genetic abnormality was detected in 53 of the 75 patients who underwent FISH testing, and the overall detection rate was 70.7% (53/75). The detection rates of 1q21 (CKS1B ) duplication, 1p32 (CDKN2C ) deletion, p53 deletion and IgH rearrangement were 48.6% (36/74), 10.6% (7/66), 11.1% (8/72) and 32.9% (24/73), respectively. The incidence of IgH rearrangement in CD117⁺ patients was significantly lower than that in CD117^- patients (P<0.05), and the proportion of 1p32 (CDKN2C ) deletion in CD200^- patients was significantly lower than that in CD200⁺ patients (P<0.05). According to the expressions of CD117 and CD200, the patients were divided into 4 groups: CD117⁺CD200⁺, CD117⁺CD200^-, CD117^-CD200⁺ and CD117^-CD200^-. Further analysis showed that the incidence of IgH rearrangement in the CD117⁺CD200^- group was significantly lower than that in the CD117^-CD200⁺ group (P<0.05), and the deletion rate of 1p32 (CDKN2C ) gene in CD117⁺CD200^- group was significantly lower than that in CD117⁺CD200⁺ group and CD117^-CD200⁺ group (P<0.05).

The difference in the expression patterns of CD117 combined with CD200 shows important value in judging the prognosis of MM patients, and the MM patients with CD117^-CD200⁺ expression patterns in abnormal plasma cells have a worse prognosis.